New pill could help control blood sugar in type 2 diabetes

NCT ID NCT05731544

Completed Disease control Sponsor: Biomea Fusion Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 30 times

Summary

This study tested a new oral drug called BMF-219 in healthy adults and people with type 2 diabetes. The goal was to see if it is safe and how it affects blood sugar control over 26 weeks. The trial involved 443 participants and compared the drug to a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ark Clinical Research

Long Beach, California, 90815, United States
Ark Clinical Research, LLC

Fountain Valley, California, 92708, United States
Avantis Clinical Research

Miami, Florida, 33155, United States
BC Diabetes

Vancouver, British Columbia, V5Y 3W2, Canada
BioPharma Services Inc.

Toronto, M9L 3A2, Canada
Carolina Research Center

Shelby, North Carolina, 28150, United States
Catalina Research Institute, LLC

Montclair, California, 91763, United States
Cedar Crosse Research Center

Chicago, Illinois, 60607, United States
Centricity Research LMC

Toronto, Ontario, M4G 3E8, Canada
Century Research LLC

Miami, Florida, 33173, United States
Clinical Trials of Texas, LLC

San Antonio, Texas, 78229, United States
David Kavtaradze MD, Inc

Cordele, Georgia, 31015, United States
Diabetes & Glandular Disease Clinic, P.A.

San Antonio, Texas, 78229, United States
Diabetes and Endocrinology Associates of Stark County

Canton, Ohio, 44718, United States
Entrust Clinical Research

Miami, Florida, 33176, United States
G+C Research Group

Hialeah, Florida, 33010, United States
Hope Clinical Research

Canoga Park, California, 91303, United States
IMA Clinical Research

Austin, Texas, 78745, United States
IMA Clinical Research Manhattan

New York, New York, 10036, United States
IMA Clinical Research St. Louis

St Louis, Missouri, 63117, United States
Manassas Clinical Research

Manassas, Virginia, 20110, United States
Medical Care, LLC

Elizabethton, Tennessee, 37643, United States
Metro Clinical Trials

San Bernardino, California, 92404, United States
Omera Health

Brooklyn, New York, 11220, United States
Panax Clinical Research

Miami Lakes, Florida, 33014, United States
Privia Medical Group

Savannah, Georgia, 31406, United States
Santa Rosa Medical Centers of Nevada

Las Vegas, Nevada, 89119, United States
Simcare Medical Research

Sugar Land, Texas, 77478, United States
Southwest General Healthcare Center

Fort Myers, Florida, 33907, United States
Sunbright Health Research Centers

Homestead, Florida, 33032, United States
Synergy Group Medical

Houston, Texas, 77061, United States
Synergy Group Medical

Missouri City, Texas, 77459, United States
Synergy Groups Medical LLC

Houston, Texas, 77036, United States
Velocity Clinical Research

La Mesa, California, 91942, United States
Velocity Clinical Research

Dallas, Texas, 75230, United States
Velocity Clinical Research

Waco, Texas, 76710, United States
Velocity Clinical Research

Jordan, Utah, 84088, United States
Wake Forest Health Network, LLC, Medical Plaza

Winston-Salem, North Carolina, 27104, United States
Zenos Clinical Research

Dallas, Texas, 75230, United States

Conditions

Explore the condition pages connected to this study.

TYPE 2 DIABETES MELLITUS